EPCAM and metastatic prostate carcinoma: However, because CTCs expressing low EpCAM levels are frequently missed using CellSearch® [46], it is likely that anti-PSMA capture maybe be a more consistent methodology for CTC isolation in metastatic prostate cancer patients.